• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Lesar David J bought $1,003,440 worth of shares (37,000 units at $27.12) (SEC Form 4)

    11/13/23 4:27:51 PM ET
    $CNP
    Electric Utilities: Central
    Utilities
    Get the next $CNP alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    LESAR DAVID J

    (Last) (First) (Middle)
    1111 LOUISIANA

    (Street)
    HOUSTON TX 77002

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    CENTERPOINT ENERGY INC [ CNP ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    CEO
    3. Date of Earliest Transaction (Month/Day/Year)
    11/13/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 11/13/2023 P 37,000 A $27.12 37,000 I By GreenStream Resources LLC
    Common Stock 1,308,522(1)(2) D
    Common Stock 278,412 I By Spouse
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Includes (i) 93,119 time-based restricted stock units ("RSUs") awarded under the Issuer's long-term incentive plan (the "Plan") and vesting in February 2024, (ii) 78,851 RSUs awarded under the Plan and vesting in February 2025 and (iii) 84,964 RSUs awarded under the Plan and vesting in February 2026. The awards shall vest (a) if Reporting Person ("R.P.") remains an employee through the vesting date, (b) upon earlier disability or death, or (c) on a pro-rata basis upon earlier retirement unless full vesting conditions satisfied. However, the vesting of each award is conditioned upon positive operating income in the last full calendar year of the restricted period except in the case of death or disability.
    2. Also includes 600,000 RSUs awarded under the Plan and vesting in December 2023. The above award shall vest (a) if R.P. continues to be an employee of Issuer from the grant date; (b) in the event of the R.P.'s earlier disability or death; or (c) upon the R.P.'s termination of employment without cause or the R.P.'s resignation for good reason.
    Remarks:
    Vincent A. Mercaldi, Attorney-in-Fact 11/13/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CNP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CNP

    DatePrice TargetRatingAnalyst
    4/22/2025$37.00Underweight → Equal Weight
    Barclays
    4/2/2025$42.00Buy
    Jefferies
    3/11/2025$36.00 → $37.00In-line → Outperform
    Evercore ISI
    1/23/2025Buy → Neutral
    Guggenheim
    12/12/2024$34.50Buy
    Ladenburg Thalmann
    12/3/2024$31.00 → $37.00Neutral → Buy
    UBS
    9/12/2024$29.00Neutral
    BofA Securities
    8/13/2024$32.00 → $28.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings